We have demonstrated that, in cross-sectional analysis, patients who develop TB-IRIS have a higher frequency of IFNγ-secreting T cells recognizing MTB antigens, compared to similar patients treated for both HIV-1 and TB who did not develop IRIS. This evidence concerns the gene IFNG and tuberculosis.